Rapport Therapeutics, Inc.Rapport Therapeutics, Inc.Rapport Therapeutics, Inc.

Rapport Therapeutics, Inc.

No trades

Fundamentals and stats

The company's current financial position

Total assets for Q3 25 are 535.32 M USD, 87.51% more than in Q2 25. And total liabilities increased by 7.84% in Q3 25 to 23.71 M USD.

Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Total assets
Total liabilities
Currency: USD
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
Q3 '25
Total assetsYoY growth
Total equityYoY growth